KBS_Icon_questionmark link-ico

Go to…

Metabolic Surgery for Type 2 Diabetes: Evidence, Indications, Obesity Stigma & Access to Care

Park Plaza Westminster Bridge, London

10 Sep NEV-main-LondonLandscape

Metabolic Surgery for Type 2 Diabetes: Evidence, Indications and Barriers to Accessing Evidence-Based Therapies for Obesity-Related Diseases

Director: Professor Francesco Rubino

Programme Co-Chairs: Professor Rachel Batterham, Dr. Alex Miras

Background:

On the back of a large body of biological, clinical and economic evidence, recent international guidelines formally endorsed by more than 50 major worldwide organizations, including Diabetes UK, recommend that gastrointestinal operations originally intended for weight loss (“bariatric surgery”) be used as standard treatment options for patients with obesity and type 2 diabetes, a practice referred to as metabolic surgery.

Despite compelling evidence and broad professional consensus, however, still only 0.1-2% of surgical candidates have access to metabolic surgery. Barriers to access of surgery are likely multi-factorial, including insufficient awareness among healthcare providers, inadequate coverage, as well as misconceptions about surgery, obesity, and diabetes.

Methods and Objectives:

Leading medical experts and stakeholders, including commissioners, regulators, MPs, patients advocacy groups, and member of the media, will discuss the following topics:

  • Clinical, Biological and Economic Evidence supporting Surgical Treatment of Type 2 Diabetes
  • Current NICE recommendations and International Guidelines about indications to Bariatric and Metabolic Surgery
  • Inadequate utilization of metabolic/bariatric surgery in the UK and Europe
  • The role of misconceptions and stigma of obesity as barriers to access of surgical and non-surgical therapies of obesity and diabetes

Who should Attend: GPs, Commissioners, Endocrinologists, Surgeons, Hospital Managers, Dietitians/Nutritionists, MPs, Members of the Media

For more information and pre-registration, contact Lillian.mccredie@kcl.ac.uk

Hosted by King’s College London with the support of Diabetes UK.

Agenda

08:30-9:00 Welcome and Registration
09:00-12:45 Metabolic Surgery for Type 2 Diabetes: Evidence, Indications, Uptake and Barriers to Access
09:00-9:30

Introduction: Metabolic/Diabetes Surgery: between evidence and stigma.

Professor F. Rubino (UK)

09:30-9:50

Biological Evidence for Surgical Treatment of T2DM           

Professor F. Pattou (France)

09:50-10:10

Clinical Evidence for Surgical Treatment of T2DM

Professor G. Mingrone (Italy)

10:10-10:30

Economic Evidence for Surgical Treatment of T2DM

TBA

10:30-10:50 Coffee
10:50-11:05

Global and National Guidelines: Indications and Model of Care

Professor R. Batterham (UK)

11:05-11:20

Current Uptake in UK, EU and USA

TBA

11:20-12:45

PANEL and audience response:

Barriers to Access of Diabetes Surgery: Awareness (Lack of), Costs or Stigma/Misconceptions?

Panelists TBA

12:45-13:30 Lunch
13:30-17:00 Mini-Symposium: Are Misconceptions and Stigma of Obesity Holding Back Evidence-Based Therapies?
13:30-13:45

Misconceptions and Stigma of Obesity

Professor F. Rubino (UK)

13:45-14:00 

The Obesity Stigma in Healthcare

TBA

14:00-14:15 

The Obesity Stigma in the Media

Dr. Stuart Flint (UK)

14:15:14:30

The Root Cause of the Stigma: A Misunderstanding of the Biology of Body Weight Regulation

Professor L. Kaplan (USA)

14:30-14:45

How misconceptions and stigma undermine access to surgical therapies of obesity and related diseases

TBA

14:45-15:00

How misconceptions and stigma undermine access to pharmacological treatments of obesity and diabetes

Dr. A. Miras (UK)

15:00-15:20 Coffee
15:20- 17:00

PANEL and audience response:

Ending discrimination against people with obesity in the healthcare and society at large to ensure equitable access to evidence-based therapies: Proposals for a road map

Panelists TBA

 


Search for another event